Colton MD, et al. - Across the adolescents and young adults (AYA) age continuum in the United States, survival inequalities related to insurance status were addressed in this study utilizing the Surveillance, Epidemiologic, and End Results database. Researchers identified 66,556 AYA patients with 10 International Classification of Childhood Cancer diagnoses. Independent of stage at diagnosis, insurance status was identified as a statistically significant predictor of mortality for lymphoid leukemia (age 15-19, 30-34, and 35-39), acute myeloid leukemia (age 15-19 and 25-29), Hodgkin lymphoma (all ages), non-Hodgkin lymphoma (age 20-24, 25-29, 30-34, and 35-39), astrocytomas (age 30-34), other gliomas (age 25-29, 30-34, and 35-39), hepatic carcinomas (age 25-29), fibrosarcomas, peripheral nerve and other fibrous tumors (age 30-34), malignant gonadal germ cell tumors (age 20-24, 25-29, 30-34, and 35-39), and other and unspecified carcinomas (age 20-24, 25-29, 30-34, and 35-39). Based on insurance status, disparities were evident in cancer survival among AYA in the US, independent of late stage of presentation. Particularly, vulnerability to health outcomes related to poor socioeconomic status, treatment inequalities, and poor access to care could be seen among patients age 26-39.